欧股 “十一罗汉” 收盘播报｜阿斯麦三季度涨超 22%，路易威登母公司涨超 16%，GSK 涨 12%，诺和诺德跌超 21%

On Tuesday (September 30), GlaxoSmithKline's London stock price (GSK.LN) closed up 3.64%, with a cumulative increase of 8.40% in September and a cumulative increase of 12.02% in the third quarter.

Roche Holding (ROG.SW) closed up 1.37%, with a cumulative decrease of 0.15% in September and a cumulative decrease of 0.65% in the third quarter.

Nestlé (NESN.SW) closed up 1.36%, with a cumulative decrease of 3.08% in September and a cumulative decrease of 7.84% in the third quarter.

Novartis (NOVN.SW) closed up 1.08%, with a cumulative decrease of 1.03% in September and a cumulative increase of 4.10% in the third quarter.

SAP (SAP.GR) closed up 1.04%, with a cumulative decrease of 1.64% in September and a cumulative decrease of 11.72% in the third quarter.

L'Oréal (OR.FP) closed up 0.95%, with a cumulative decrease of 7.39% in September and a cumulative increase of 1.49% in the third quarter.

AstraZeneca (AZN.LN) closed up 0.85%, with a cumulative decrease of 5.16% in September and a cumulative increase of 9.37% in the third quarter.

Sanofi (SAN.FP) closed up 0.34%, with a cumulative decrease of 7.03% in September, after a gap down on September 4 and continued low-level fluctuations, with a cumulative decrease of 4.45% in the third quarter.

ASML Holding's Amsterdam stock price (ASML.NA) closed up 0.31%, with a cumulative increase of 30.08% in September and a cumulative increase of 22.28% in the third quarter.

LVMH Group (MC.FP) closed down 0.50%, with a cumulative increase of 3.25% in September and a cumulative increase of 16.40% in the third quarter.

Novo Nordisk's Copenhagen stock price (NOVOB.DC) closed down 1.96%, with a cumulative decrease of 3.94% in September and a cumulative decrease of 21.60% in the third quarter, continuing low-level fluctuations after a sharp drop on July 29